No clinical studies found
No published clinical study of AHK-Cu was identified on PubMed. The available record is preclinical cell work and user reported experience. Reported in the cited paper.
SourceResearch Use Only. Products listed are not for human or animal consumption. Statements have not been evaluated by the FDA.View full disclaimers →
The directory
83 listed
Newsletter · Quarterly
Get notified about new lab results, price drops and supplier coupons before everyone else.
We respect your privacy. No spam.
AHK-Cu is a copper bound tripeptide of alanine, histidine and lysine, part of the same copper peptide family as GHK-Cu. It is studied for hair follicle stimulation and scalp health, and is used almost entirely in topical cosmetic formulations.
Vendor listings
Show prices as
18 listings · AHK-Cu
In stock20mgseen 4d ago
In stock100mgseen 4d ago
In stock50mgseen 4d ago
In stock100mgseen 4d ago
In stock100mgseen 4d ago
In stock100mgseen 4d ago
In stock50mgseen 4d ago
In stock100mgseen 7d ago
In stock50mgseen 4d ago
In stock100mgseen 4d ago
In stock100mgseen 3d ago
In stock100mgseen 3d ago
In stock50mgseen 4d ago
In stock50 mg · 10 vialsseen 3d ago
Out of stock50mgseen 6d ago
Out of stock50mgseen 3d ago
Out of stock100mgseen 4d ago
Out of stock100mgseen 3d ago
Overview
AHK-Cu is a copper bound tripeptide of alanine, histidine and lysine, part of the same copper peptide family as GHK-Cu. It is studied for hair follicle stimulation and scalp health, and is used almost entirely in topical cosmetic formulations.
What the research reports
Outcomes described across the published AHK-Cu literature and ongoing study. Read each as research context rather than a promised personal result.
Hair follicle study research
Studied for effects on dermal papilla cells, the follicle structures that regulate the hair growth cycle, mainly in cell culture work. Reported in research settings.
Keratinocyte support study
Preclinical work describes support for keratinocyte proliferation, the cell type that forms the structural protein in hair and skin. Reported in research settings.
Copper cofactor delivery role
Copper acts as a cofactor for enzymes involved in tissue remodelling, which is the shared rationale across copper peptides. Reported in research settings.
Topical cosmetic serum use
Sold mainly in serums applied to the scalp, a low risk route compared with the injectable compounds elsewhere in this directory. Reported in research settings.
Companion to GHK-Cu peptide
Often formulated alongside GHK-Cu, where the two copper peptides target hair and skin outcomes respectively. Noted across the published research record.
Dosage and protocol
No standard published protocol exists. Topical serums use low concentration formulations applied to a clean scalp once or twice daily on an ongoing basis for cosmetic use.
Clinical evidence
The published AHK-Cu record, labeled by strength so you can see what is settled and what is still emerging.
No published clinical study of AHK-Cu was identified on PubMed. The available record is preclinical cell work and user reported experience. Reported in the cited paper.
SourceThe broader copper peptide literature covers wound healing and tissue remodelling, which is the closest published context for this compound. Reported in the cited paper.
SourceThe related peptide GHK-Cu has a small randomised trial after laser resurfacing that found no measurable change in redness or wrinkles. Reported in the cited paper.
SourceInteractions
Questions